STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug Administration of China (CNDA, former CFDA) of its Category 1 new drug, Ganovo (also known as Danoprevir or ASC08), to treat viral hepatitis C. Ganovo is the first Direct-acting Anti-viral Agent (DAA) developed by a domestic company in China and has been…